Lee Sang Pyo, Kim Jeong Hwan, Sung In-Kyung, Lee Sun-Young, Park Hyung Seok, Shim Chan Sup, Han Hye Seung
Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea.
J Gastroenterol Hepatol. 2015 May;30(5):872-8. doi: 10.1111/jgh.12886.
Endoscopic submucosal dissection (ESD) is now commonly performed as a treatment for colorectal tumors. However, little is known about the relationship between submucosal fibrosis and the outcome of the colonic ESD procedure. The aims of this study were to investigate the relationship between the degree of submucosal fibrosis in colorectal tumors and the outcomes of ESD for these tumors and to evaluate the risk factors for submucosal fibrosis.
We retrospectively reviewed the records of patients with colorectal adenoma or carcinoma who had undergone an ESD, during a four-year period from January 2010 to December 2013. The resected specimens were histologically examined after Masson's trichrome staining, and the severity of the submucosal fibrosis was classified as no fibrosis (F0), mild fibrosis (F1), or severe fibrosis (F2).
Among a total of 173 cases (106 male, mean age 65.0 ± 10.2 years; F0 33, F1 78, F2 62) enrolled, 46 incidences of complications (perforation 19, post-coagulation syndrome 21, bleeding 6) had developed. Multivariate analysis revealed that F2 fibrosis was significantly associated with the development of complications. Submucosal invasion and large tumor size (≥ 30 mm) were identified as independent predictors of F2 fibrosis.
Severe fibrosis is the most powerful risk factor for complications and can interfere with en bloc resections. The possibility of submucosal fibrosis should be considered, and the procedure should be cautiously performed in cases where the tumor diameter is greater than 30 mm and when submucosal cancer is suspected.
内镜黏膜下剥离术(ESD)目前常用于治疗结直肠肿瘤。然而,关于黏膜下纤维化与结肠ESD手术结果之间的关系,人们知之甚少。本研究的目的是探讨结直肠肿瘤黏膜下纤维化程度与这些肿瘤ESD手术结果之间的关系,并评估黏膜下纤维化的危险因素。
我们回顾性分析了2010年1月至2013年12月四年间接受ESD治疗的结直肠腺瘤或癌患者的病历。切除标本经Masson三色染色后进行组织学检查,黏膜下纤维化的严重程度分为无纤维化(F0)、轻度纤维化(F1)或重度纤维化(F2)。
在总共纳入的173例患者(男性106例,平均年龄65.0±10.2岁;F0 33例,F1 78例,F2 62例)中,发生了46例并发症(穿孔19例,凝固后综合征21例,出血6例)。多因素分析显示,F2纤维化与并发症的发生显著相关。黏膜下浸润和肿瘤大尺寸(≥30 mm)被确定为F2纤维化的独立预测因素。
严重纤维化是并发症的最有力危险因素,可干扰整块切除。应考虑黏膜下纤维化的可能性,对于肿瘤直径大于30 mm且怀疑有黏膜下癌的病例,手术应谨慎进行。